5Flashner-Barak, Moshe, Rosenberger, et al. Composition and dosage form for delayed gastric release of alendronate and/or other bis - phosphonates[ P ] . United States Patent : 6476006, 2002 11 - 05.
6Kuljanin J,Jankovic I,Nedeljkovic J,et al.Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions[J].J Pharm Biomed Anal,2002,28(6):1215
7Yun MH,Kwon KI.High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence:application to a pharmacokinetic study in humans[J].J Pharm Biomed Anal,2006,40(1):168
8Tsai E.W,Singh M.M,Lu H.H,et al.Application of capillary electrophoresis to phammceutical analysis-determination of alendronate in dosage forms[J].J Chromatogr,1992,626:245.
9Reed D.G,Martin G.P,Konieczny J.M,et al.The determination of alendronate sodium in tablets by inductively coupled plasma(ICP)[J].J Pharm Biomed Anal,1995,13(8):1055
